Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Lisata Therapeutics, Inc. (LSTA) had Income from Continuous Operations of $-2.93M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.93M |
|
-- |
|
-- |
|
$3.99M |
|
$-3.99M |
|
$1.06M |
|
$-2.93M |
|
$-2.93M |
|
$-2.93M |
|
|
Income from Continuous Operations |
$-2.93M |
$-2.93M |
|
$-2.93M |
|
$-3.99M |
|
$-3.99M |
|
9.11M |
|
9.11M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$11.01M |
|
$0.01M |
|
$0.01M |
|
$11.03M |
|
$2.99M |
|
-- |
|
$0.05M |
|
$3.04M |
|
$7.99M |
|
$7.99M |
|
$7.99M |
|
9.12M |
|
| Cash Flow Statement Financials | |
$-5.73M |
|
-- |
|
$0.21M |
|
$15.96M |
|
$10.44M |
|
$-5.51M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-36.66% |
|
-36.66% |
|
-26.56% |
|
-36.66% |
|
$0.88 |
|
$-0.63 |
|
$-0.63 |
|